HHT care at Mayo Clinic

Your Mayo Clinic care team

At Mayo Clinic in Rochester, Minnesota, specialists from across departments work together to diagnose and treat patients with HHT. These include specialists in medical genetics, cardiovascular diseases, pulmonary medicine and critical care, neurology, neurosurgery, ear, nose and throat (ENT), radiology, and gastroenterology and hepatology.

Nationally recognized expertise

Mayo Clinic is a hereditary hemorrhagic telangiectasia care (HHT) Center of Excellence. This means that Mayo Clinic is one of only a few medical centers designated by the HHT Foundation as expert in diagnosing and treating all aspects of this disorder and providing whole-person care that meets the needs of people with HHT.

In addition, Mayo Clinic offers in-house genetic testing for the three most common genes associated with HHT (ACVRL1, ENG and SMAD4).

Advanced diagnosis and treatment

Highly skilled Mayo Clinic specialists use advanced diagnostic tools and offer the latest treatments for HHT.

Jan. 19, 2016
References
  1. AskMayoExpert. Hereditary hemorrhagic telangiectasia. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  2. Hereditary hemorrhagic telangiectasia — HHT. Society of Interventional Radiology. http://www.sirweb.org/patients/hereditary-hemorrhagic-telanglectasia. Accessed Nov. 9, 2015.
  3. Cummings KW, et al. Pulmonary vascular diseases. Clinics in Chest Medicine. 2015;36:235.
  4. Feldman M, et al. Vascular disorders of the gastrointestinal tract. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 10th ed. Philadelphia, Pa.: Saunders Elsevier; 2016. http://www.clinicalkey.com. Accessed Nov. 10. 2015.
  5. Epperia N, et al. Blessing for the bleeder: Bevacizumab in hereditary hemorrhagic telangiectasia. Clinical Medicine Research. 2015;13:32.
  6. Wain K, et al. Hereditary hemorrhagic telangiectasia and risks for adverse pregnancy outcomes. American Journal of Genetics. Part A. 2012;158A:2009.
  7. EASL Clinical Practice Guidelines: Vascular diseases of the liver. Journal of Hepatology. In press. Accessed Nov. 17, 2015.
  8. Camaschella C. Iron-deficiency anemia. New England Journal of Medicine. 2015;372:1832.
  9. Shovlin C. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). http://www.uptodate.com/home. Accessed Nov. 10, 2015.
  10. About HHT. HHT Foundation. http://curehht.org. Accessed Nov. 17, 2015.
  11. Gossage JR. Therapeutic approach to adult patients with pulmonary arteriovenous malformations. http://www.uptodate.com/home. Accessed Nov. 17, 2015.
  12. Barbara Woodward Lips Patient Education Center. Hereditary hemorrhagic telangiectasia. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2005.
  13. Patient information: Arteriovenous malformations in the brain (The Basics). http://www.uptodate.com/home. Accessed Nov. 17, 2015.
  14. Gossage JR. Pulmonary arteriovenous malformations: Clinical features and diagnostic evaluation in adults. http://www.uptodate.com/home. Accessed Nov. 17, 2015.